Key Record Dates
ClinicalTrials.gov Identifier: | NCT02846623 |
---|---|
Brief Title: | Atezolizumab, Obinutuzumab, and Venetoclax in Treating Patients With Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or Relapsed or Refractory Richter Syndrome |
First Submitted : | July 22, 2016 |
First Submitted that Met QC Criteria : | July 22, 2016 |
First Posted : | July 27, 2016 (Estimate) |
Last Update Submitted that Met QC Criteria : | August 15, 2019 |
Last Update Posted : | August 19, 2019 |